The gamma 1 heavy-chain disease FOR protein is present in two molecular forms
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
6430761
DOI
10.1007/bf02877317
Knihovny.cz E-zdroje
- MeSH
- imunoglobuliny - gama-řetězce izolace a purifikace MeSH
- lidé MeSH
- nemoc z těžkých řetězců MeSH
- sekvence aminokyselin MeSH
- těžké řetězce imunoglobulinů izolace a purifikace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- FOR heavy chain disease protein, human MeSH Prohlížeč
- heavy chain disease proteins, human MeSH Prohlížeč
- imunoglobuliny - gama-řetězce MeSH
- těžké řetězce imunoglobulinů MeSH
Heavy chain disease proteins (FOR) were isolated from human plasma. These proteins were also detected immunochemically in the urine of the patient. The proteins were disulphide-linked Fc-like dimers with molar mass 64.2 kg/mol and sedimentation rate S020,W = 0.356 ps (3.56 S). Similar amounts of aspartic acid and pyroglutamic acid were found at the N-terminus. After cyanogen bromide cleavage of the FOR proteins, three peptides were isolated and their amino acid composition and partial amino acid sequence was determined. We suggest that two Fc-like proteins of similar sizes are present in the plasma: (1) the first with N-terminal aspartic acid corresponding to position 221 of gamma 1 EU chain and (2) the second with N-terminal pyroglutamic acid. The first protein and small amounts of related low-molar mass fragments found also in the plasma could be degradation products of the second protein. Evidence is given on structural differences between the FOR proteins and the corresponding portion of the gamma 1 EU chain.
Zobrazit více v PubMed
Proc Natl Acad Sci U S A. 1979 Jan;76(1):452-6 PubMed
Biochem J. 1951 Jan;48(1):126-8 PubMed
Hoppe Seylers Z Physiol Chem. 1976 Nov;357(11):1571-604 PubMed
J Exp Med. 1939 Jan 1;69(1):103-18 PubMed
Nature. 1979 Feb 22;277(5698):627-33 PubMed
Biochemistry. 1973 Aug 14;12(17):3355-9 PubMed
Biochem J. 1966 Aug;100(2):303-8 PubMed
Scand J Immunol. 1980;11(6):601-7 PubMed
Proc Natl Acad Sci U S A. 1969 May;63(1):78-85 PubMed
Proc Natl Acad Sci U S A. 1971 Jan;68(1):187-91 PubMed
Biochemistry. 1968 Oct;7(10):3340-4 PubMed
J Biol Chem. 1948 Oct;176(1):367-88 PubMed
Biochim Biophys Acta. 1967 Feb 21;133(2):369-70 PubMed
Am J Med. 1964 Sep;37:332-50 PubMed
J Biol Chem. 1969 Aug 25;244(16):4406-12 PubMed
Ann N Y Acad Sci. 1971 Dec 31;190:467-71 PubMed
Biochemistry. 1964 Mar;3:297-317 PubMed
Nature. 1969 Mar 22;221(5186):1166-9 PubMed
Cesk Epidemiol Mikrobiol Imunol. 1958 Nov;7(6):414-7 PubMed
Nature. 1978 Jun 1;273(5661):400-1 PubMed
Scand J Immunol. 1972;1(1):53-62 PubMed
Immunochemistry. 1976 Mar;13(3):245-9 PubMed
Blood. 1970 Aug;36(2):137-44 PubMed
Immunol Today. 1980 Jul;1(1):10-7 PubMed
Immunochemistry. 1969 Jan;6(1):53-66 PubMed
J Immunol Methods. 1972 Nov;2(1):67-74 PubMed
Nature. 1978 Dec 21-28;276(5690):790-5 PubMed
Science. 1968 Dec 20;162(3860):1396-7 PubMed
Biochemistry. 1968 May;7(5):1959-66 PubMed
J Immunol. 1978 Dec;121(6):2582-3 PubMed
Science. 1966 Feb 25;151(3713):988-90 PubMed
Arch Biochem Biophys. 1969 Nov;134(2):279-84 PubMed
Biochem J. 1945;39(5):507-15 PubMed
FEBS Lett. 1972 Feb 15;20(3):321-323 PubMed